Article
Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells.
Anti-cancer drugs - 1 Feb 1991
Bouffard D Y, Momparler L F, Momparler R L
Abstract excerpt
2',2'-difluorodeoxycytidine (known as dFdC, Gemcitabine and LY188011) is a new analog of deoxycytidine which has demonstrated excellent antineoplastic activity against many kinds of solid tumors and leukemic cell lines. We were interested in the comparison of the antineoplastic activity of this new antimetabolite with cytosine arabinoside (ARA-C) against HL-60 myeloid, RPMI-8392 B-lymphoid and Molt-3 T-lymphoid...
Topics
- Antimetabolites, Antineoplastic
- Cell Division
- Cytarabine
- DNA, Neoplasm
- Deoxycytidine
- Humans
- Kinetics
- Leukemia, Experimental
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Phenotype
